CSIMarket
 


Casi Pharmaceuticals inc   (CASI)
Other Ticker:  
 

Casi Pharmaceuticals Inc 's Working Capital Ratio

CASI's quarterly Working Capital Ratio and Current Assets, Current Liabilities growth




CASI Working Capital Ratio (Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Current Liabilities Change 198.74 % 31.47 % 39.14 % 65.32 % 79.26 %
Y / Y Current Assets Change -22.72 % -49.36 % -40.8 % -16.29 % -13.59 %
Working Capital Ratio MRQ 1.87 3.21 3.8 4.7 7.23
Overall Ranking # # # # #
Seq. Current Liabilities Change 125.8 % -5.02 % 5.2 % 32.42 % -0.63 %
Seq. Current Assets Change 31.52 % -19.76 % -14.97 % -13.89 % -13.82 %



Working Capital Ratio third quarter 2022 Comment
Due to increase in Current Liabilities in the third quarter 2022, Working Capital Ratio fell to 1.87 above Casi Pharmaceuticals Inc average.

Within Biotechnology & Pharmaceuticals industry Casi Pharmaceuticals inc booked the highest Working Capital Ratio than Casi Pharmaceuticals Inc in the third quarter 2022. While total ranking remained unchanged compare to previous quarter at no. .

Explain Working Capital Ratio
Where is CASI most successful ?
Working Capital Ratio CASI on the trailing twelve month basis
Working Capital Ratio third quarter 2022 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall Market #


Working Capital Ratio Statistics
High Average Low
0 0 0
 




Financial Statements
Casi Pharmaceuticals Inc 's Current Liabilities $ 30 Millions Visit CASI's Balance sheet
Casi Pharmaceuticals Inc 's Current Assets $ 56 Millions Visit CASI's Balance sheet
Source of CASI's Sales Visit CASI's Sales by Geography


Cumulative Casi Pharmaceuticals Inc 's Working Capital Ratio

CASI's Working Capital Ratio for the trailling 12 Months

CASI Working Capital Ratio

(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Current Liabilities TTM Growth 198.74 % 31.47 % 39.14 % 65.32 % 79.26 %
Y / Y Current Assets TTM Growth -22.72 % -49.36 % -40.8 % -16.29 % -13.59 %
Working Capital Ratio TTM 3.04 4.56 5.74 7.1 8.4
Total Ranking TTM # 1216 # 1119 # 920 # 651 # 527
Seq. Current Liabilities TTM Growth 125.8 % -5.02 % 5.2 % 32.42 % -0.63 %
Seq. Current Assets TTM Growth 31.52 % -19.76 % -14.97 % -13.89 % -13.82 %


TTM Working Capital Ratio Comment
On the trailing twelve months basis Due to doubling in Current Liabilities in the III. Quarter to $29.75 millions, average cumulative Working Capital Ratio decreased to 3.04 below the Casi Pharmaceuticals Inc average Working Capital Ratio.
Working Capital Ratio is the average cumulative value over the last four quarters.

Among companies operatig within Biotechnology & Pharmaceuticals industry 164 other companies have achieved higher Working Capital Ratio than Casi Pharmaceuticals Inc . While overall ranking remained unchanged compare to previous quarter at no. 1216.

Explain Working Capital Ratio
Where is CASI most successful ?
Working Capital Ratio CASI on the trailing twelve month basis

TTM Working Capital Ratio Company Ranking
Within: No.
Within the Biotechnology & Pharmaceuticals Industry # 165
Healthcare Sector # 623
Within the Market # 1216


TTM Working Capital Ratio Statistics
High Average Low
20.32 11.13 3.04
(Dec 31 2018)   (Sep 30 2022)




Companies with similar Working Capital Ratio in the quarter ending Sep 30 2022, within Biotechnology & Pharmaceuticals Industry Working Capital RatioSep 30 2022 MRQ Current AssetsSep 30 2022 MRQ Current Liabilities
Iovance Biotherapeutics inc   5.13 $ 369.884  Millions$ 72.074  Millions
Intuitive Surgical Inc   5.10 $ 6,293.100  Millions$ 1,233.400  Millions
Tcr2 Therapeutics Inc   5.02 $ 184.079  Millions$ 36.693  Millions
10x Genomics Inc   4.96 $ 629.422  Millions$ 126.855  Millions
Standard Biotools Inc   4.96 $ 229.017  Millions$ 46.169  Millions
Palisade Bio Inc   4.95 $ 15.158  Millions$ 3.060  Millions
Logicmark Inc   4.95 $ 11.772  Millions$ 2.381  Millions
Aligos Therapeutics Inc   4.91 $ 150.093  Millions$ 30.541  Millions
Telesis Bio Inc   4.86 $ 62.185  Millions$ 12.808  Millions
Inogen Inc   4.83 $ 317.776  Millions$ 65.736  Millions
Alector Inc   4.82 $ 774.963  Millions$ 160.889  Millions
Microbot Medical Inc   4.81 $ 6.603  Millions$ 1.372  Millions
Gritstone Bio Inc   4.75 $ 153.427  Millions$ 32.313  Millions
Mymd Pharmaceuticals Inc   4.70 $ 8.077  Millions$ 1.717  Millions
Beam Therapeutics Inc   4.64 $ 1,108.912  Millions$ 238.859  Millions
Spk Acquisition Corp   4.64 $ 10.603  Millions$ 2.285  Millions
Nutriband Inc   4.62 $ 3.507  Millions$ 0.759  Millions
Fresh Tracks Therapeutics Inc   4.45 $ 14.271  Millions$ 3.206  Millions
Sana Biotechnology Inc   4.36 $ 500.250  Millions$ 114.813  Millions
Establishment Labs Holdings Inc   4.27 $ 138.165  Millions$ 32.376  Millions
Cognition Therapeutics inc   4.20 $ 50.932  Millions$ 12.116  Millions
Bio techne Corp  4.01 $ 552.031  Millions$ 137.629  Millions
Adaptimmune Therapeutics Plc  4.00 $ 264.139  Millions$ 66.080  Millions
Xtant Medical Holdings Inc   3.97 $ 45.108  Millions$ 11.359  Millions
Milestone Scientific Inc   3.95 $ 14.515  Millions$ 3.676  Millions
Atara Biotherapeutics Inc   3.92 $ 283.046  Millions$ 72.244  Millions
Natural Health Trends Corp   3.90 $ 79.012  Millions$ 20.239  Millions
Hydrofarm Holdings Group Inc   3.83 $ 186.655  Millions$ 48.725  Millions
Edwards Lifesciences Corporation  3.83 $ 3,513.900  Millions$ 917.900  Millions
Seagen Inc   3.80 $ 2,759.619  Millions$ 725.998  Millions

Date modified: 2022-11-16T03:23:24+00:00

Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

ACN's Profile

Stock Price

ACN's Financials

Business Description

Fundamentals

Charts & Quotes

ACN's News

Suppliers

ACN's Competitors

Customers & Markets

Economic Indicators

ACN's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071